WilmerHale-Led Stealth Biotherapeutics Aims For $81M IPO
Venture capital-backed Stealth Biotherapeutics Corp. on Wednesday set a price range for its planned initial public offering, as the WilmerHale-led biotechnology firm looks to raise $80.6 million at midpoint and ramp...To view the full article, register now.
Already a subscriber? Click here to view full article